CELZ (Creative Medical Technology Holdings) E10: $-6,265.15 (As of Mar. 2026)


CELZ Creative Medical Technology Holdings Inc CELZ
34 GF Score
Price $0.81
GF Value $0.32
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Creative Medical Technology Holdings E10?

Creative Medical Technology Holdings CELZ -32.48% 34 E10 is $-6,265.15 as of Mar. 2026. GuruFocus rates CELZ with a GF Score™ of 34/100 and a GF Value™ of $0.32 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Creative Medical Technology Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-6,265.15 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -0.70% per year. During the past 5 years, the average E10 Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Creative Medical Technology Holdings was -0.70% per year. The lowest was -16.10% per year. And the median was -3.25% per year.

As of today (2026-06-30), Creative Medical Technology Holdings's current stock price is $0.8102. Creative Medical Technology Holdings's E10 for the quarter that ended in Mar. 2026 was $-6,265.15. Creative Medical Technology Holdings's Shiller PE Ratio of today is .


Creative Medical Technology Holdings  (NAS:CELZ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Creative Medical Technology Holdings E10 Related Terms


Creative Medical Technology Holdings E10 Historical Data

* Premium members only.

The historical data trend for Creative Medical Technology Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Medical Technology Holdings E10 Chart

Creative Medical Technology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,562.43 -6,849.34 -6,929.83 -6,974.73 -6,986.55

Creative Medical Technology Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,015.18 -7,040.52 -7,053.61 -6,986.55 -6,265.15

CELZ vs FBLG, GLMD, ALZN: E10 Comparison

For the Biotechnology subindustry, Creative Medical Technology Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Shiller PE Ratio falls into.


CELZ
34GF Score
Creative Medical Technology Holdings Inc CELZ
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creative Medical Technology Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Creative Medical Technology Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.38/330.2130*330.2130
=-0.380

Current CPI (Mar. 2026) = 330.2130.

Creative Medical Technology Holdings Quarterly Data

per share eps CPI Adj_EPS
201606 -1,573.286 241.018 -2,155.522
201609 -1,588.993 241.428 -2,173.344
201612 -1,389.043 241.432 -1,899.831
201703 -1,725.894 243.801 -2,337.614
201706 -6,286.213 244.955 -8,474.166
201709 -370.085 246.819 -495.128
201712 -9,655.026 246.524 -12,932.676
201803 -14,233.734 249.554 -18,834.256
201806 -7,131.268 251.989 -9,345.001
201809 -1,503.368 252.439 -1,966.541
201812 1,607.939 251.233 2,113.426
201903 -600.000 254.202 -779.411
201906 -50.000 256.143 -64.459
201909 -1,194.106 256.759 -1,535.718
201912 -1,154.536 256.974 -1,483.585
202003 24.095 258.115 30.825
202006 -50.000 257.797 -64.045
202009 1.400 260.280 1.776
202012 -251.257 260.474 -318.528
202103 111.800 264.877 139.377
202106 -12.500 271.696 -15.192
202109 -7.500 274.310 -9.028
202112 -26.100 278.802 -30.913
202203 -1.800 287.504 -2.067
202206 -1.990 296.311 -2.218
202209 -0.700 296.808 -0.779
202212 -5.300 296.797 -5.897
202303 -0.750 301.836 -0.821
202306 -0.780 305.109 -0.844
202309 -1.020 307.789 -1.094
202312 -1.210 306.746 -1.303
202403 -0.730 312.332 -0.772
202406 -1.110 314.175 -1.167
202409 -0.750 315.301 -0.785
202412 -1.120 315.605 -1.172
202503 -0.830 319.799 -0.857
202506 -0.480 322.561 -0.491
202509 -0.480 324.800 -0.488
202512 -0.800 324.054 -0.815
202603 -0.380 330.213 -0.380

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-6,265.15 mean?
Creative Medical Technology Holdings (CELZ) has a E10 of $-6,265.15 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Creative Medical Technology Holdings and its competitors.
Is Creative Medical Technology Holdings' E10 too high?
Creative Medical Technology Holdings' current E10 is $-6,265.15. Overall, Creative Medical Technology Holdings has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Creative Medical Technology Holdings' E10 compare to FBLG and GLMD?
Creative Medical Technology Holdings' E10 of $-6,265.15 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Creative Medical Technology Holdings and its competitors. Creative Medical Technology Holdings's current E10 is $-6,265.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Medical Technology Holdings stock overvalued right now?
Based on GuruFocus' analysis, Creative Medical Technology Holdings (CELZ) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.32, compared to a current price of $0.81 — trading 153.2% above its estimated fair value. The current E10 is $-6,265.15. Creative Medical Technology Holdings' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Creative Medical Technology Holdings (CELZ), the current E10 is $-6,265.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creative Medical Technology Holdings (CELZ) Overvalued in 2026?

Based on GuruFocus' analysis, Creative Medical Technology Holdings stock appears to be overvalued. The current stock price of $0.81 is trading 153.2% above its estimated GF Value™ of $0.32. GuruFocus considers Creative Medical Technology Holdings to be Significantly Overvalued.

Key valuation signals for CELZ:

  • E10: $-6,265.15
  • GF Value™: $0.32 vs. price of $0.81 (153.2% above fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the CELZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Creative Medical Technology Holdings Business Description

Address 211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
34GF Score

Get the complete analysis for CELZ

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.81
Price
$0.32
GF Value